Priority Review for Alkermes Drug
Priority Review for Alkermes Drug
Recently, Alkermes announced that the US FDA will review the supplemental New Drug Application for Vivitrol for treating pioid dependence on a priority basis.
Read more on Zacks.com via Yahoo! Finance
Related posts: